KC-3870

CHOK1-cyno-CD22-Cell-Line

×
Please enable JavaScript in your browser to complete this form.
34936
Home » CHOK1-cyno-CD22-Cell-Line

Background of CHOK1-cyno-CD22-Cell-Line

CD22 (CD22 Molecule) also known as SIGLEC2, it is a Protein Coding gene. Sialic acid-binding immunoglobulin-like lectin (Siglec) receptors are a family of 14 cell surface transmembrane proteins that bind specifically to sialic acid (Sia)-containing glycans, facilitating cell adhesion and/or cell signaling1. CD22 (Siglec 2) is a receptor predominantly restricted to B cells, it is a single-spanning membrane glycoprotein of 140 kDa on the surface of B cells. The cis/trans binding modes of CD22, together with a multi-Ig domain topology imply that the biological function of CD22 might be facilitated by significant conformational plasticity. Diseases associated with CD22 include Hematologic Cancer and Refractory Hairy Cell Leukemia.

Specifications

Catalog NumberKC-3870
Cell Line NameCHOK1-cyno-CD22-Cell-Line
Host Cell LineCHOK1
DescriptionStable CHOK1 cell line expressing exogenous cyno CD22 gene
QuantityTwo vials of frozen cells (≥2-106/vial)
StabilityStable in culture over a minimum of 10 passages
ApplicationDrug screening and biological assays
Freezing Medium70% RPMI1640 + 20% FBS + 10% DMSO
Propagation MediumRPMI1640 + 10% FBS + 10μg/ml Puromycin
Selection MarkerPuromycin
MorphologyEpithelial
SubcultureSplit saturated culture 1:4-1:8 every 2-3 days; seed out at about 1-3 × 105 cells/ml
Incubation37 °C with 5% CO2
StorageLiquid nitrogen immediately upon receiving
Doubling TimeApproximately 24 hours
Mycoplasma StatusNegative
In Vivo ValidationNA

Cell Line Generation

CHOK1-cyno-CD22 Cell Line was generated using a lentiviral vector expressing the cyno CD22 sequence.

Characterization

Figure 1: Characterization of cyno CD22 overexpression in the CHO-K1 cyno CD22 stable clone using QPCR.

Figure 2: Characterization of cyno CD22 overexpression in the CHO-K1 cyno CD22 stable clone using PCR sequence.

Cell Resuscitation

  1. Prewarm culture medium (RPMI1640 supplemented with 10% FBS and 10μg/mL Puromycin)in a 37°C water bath.
  2. Thaw the frozen vial in a 37°C water bath for 1-2 minutes.
  3. Transfer the vial into biosafety cabinet, and wipe the surface with 70% ethanol.
  4. Unscrew the top of the vial and transfer the cell suspension gently into a sterile centrifuge tube containing 9.0mL complete culture medium.
  5. Spin at ~ 125 × g for 5-7 minutes at room temperature, and discard the supernatant without disturbing the pellet.
  6. Resuspend cell pellet with the appropriate volume of complete medium and transfer the cell suspension into a T25 culture flask.
  7. Incubate the flask at 37°C, 5% CO2 incubator.
  8. Split saturated culture 1:4-1:8 every 2-3 days; seed out at about 1-3 × 105 cells/mL.

Cell Freezing

  1. Prepare the freezing medium (70% RPMI1640 + 20% FBS + 10% DMSO) fresh immediately before use.
  2. Keep the freezing medium on ice and label cryovials.
  3. Transfer cells to a sterile, conical centrifuge tube, and count the cells.
  4. Centrifuge the cells at 250×g for 5 minutes at room temperature and carefully aspirate off the medium.
  5. Resuspend the cells at a density of at least 3×106 cells/mL in chilled freezing medium.
  6. Aliquot 1 mL of the cell suspension into each cryovial.
  7. Freeze cells in the CoolCell freezing container overnight in a -80°C freezer.
  8. Transfer vials to liquid nitrogen for long-term storage

References

  1. Pluvinage JV, Haney MS, Smith BAH, Sun J, Iram T, Bonanno L, Li L, Lee DP, Morgens DW, Yang AC, Shuken SR, Gate D, Scott M, Khatri P, Luo J, Bertozzi CR, Bassik MC, Wyss-Coray T. CD22 blockade restores homeostatic microglial phagocytosis in ageing brains. Nature. 2019 Apr;568(7751):187-192. doi: 10.1038/s41586-019-1088-4. Epub 2019 Apr 3. PMID: 30944478; PMCID: PMC6574119.
  2. Clark EA, Giltiay NV. CD22: A Regulator of Innate and Adaptive B Cell Responses and Autoimmunity. Front Immunol. 2018 Sep 28;9:2235. doi: 10.3389/fimmu.2018.02235. PMID: 30323814; PMCID: PMC6173129.
  3. Ereño-Orbea, J., Sicard, T., Cui, H. et al. Molecular basis of human CD22 function and therapeutic targeting. Nat Commun 8, 764 (2017).
Please enable JavaScript in your browser to complete this form.